HIGHLIGHTS
- who: Adam M. Kase and colleagues from the Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA have published the Article: Clear Cell Renal Cell Carcinoma: From Biology to Treatment, in the Journal: Cancers 2023, 15, 665. of /2023/
- what: Biological discoveries in RCC have translated into enormous therapeutic progress over the last two decades.
- future: The future is bright with more therapeutics however more translational and clinical studies are needed to determine when to use these agents based on biomarker analyses to maximize benefits and limit toxicity. This review will . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.